招银国际发报告称,升锦欣生殖(01951.HK)目标价8%,从13.3港元上调至14.4港元,维持“买入”评级。
报告指出,锦欣生殖3.2亿人民币收购武汉黄浦中西医结合妇产医院75%的股权,相信公司将会继续通过并购扩大。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”